Literature DB >> 9368347

Extrinsic control of stem cell fate: practical considerations.

M Mielcarek1, J Reems, B Torok-Storb.   

Abstract

Decades of experimental data suggest that hematopoietic stem cells can remain quiescent, divide, differentiate or die and further, that these cell fate decisions are determined by extracellular signals provided by the hematopoietic microenvironment (ME). Given the importance of the ME for regulating hematopoiesis, it is imperative that transplanted stem cells migrate efficiently and home to appropriate niches where they can receive regulatory signals. Currently the rapid engraftment seen after transplantation of cytokine-mobilized blood-derived stem cells would suggest that these cells are well-equipped for homing. More recent concerns have now been raised by the possibility that in vitro expansion of these stem cells may diminish their ability to engraft. One possible explanation for this is that expansion protocols may alter adhesion molecule expression and consequently homing. Data presented in this report indicate that expression of adhesion molecules is altered following in vitro exposure to recombinant cytokines, and that various combinations of cytokines differentially modulate adhesion molecule expression.

Entities:  

Mesh:

Year:  1997        PMID: 9368347     DOI: 10.1002/stem.5530150831

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  2 in total

1.  Genomic and proteomic analysis of the impact of mitotic quiescence on the engraftment of human CD34+ cells.

Authors:  Brahmananda Reddy Chitteti; Yunlong Liu; Edward F Srour
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

Review 2.  Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia.

Authors:  Julien M P Grenier; Céline Testut; Cyril Fauriat; Stéphane J C Mancini; Michel Aurrand-Lions
Journal:  Front Immunol       Date:  2021-11-12       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.